Teriflunomide 14 mg
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Teriflunomide 14 mg, covering 2023-03-22 to 2023-03-22. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety of Long Term Treatment With Teriflunomide 14 mg Once Daily in Patients With a First Clinical Episode Suggestive of Multiple Sclerosis in a Long-term Extension Period [Phase 3]